Cancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September
/
Date21 Sep 2016
RUTHERFORD, N.J., Sept. 21, 2016 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through... Read More →
athenahealth Launches athenaInsight, a New Editorial Hub Reporting from the Heart of the Healthcare Internet
/
Date21 Sep 2016
Commits to Data and Knowledge Sharing from its National Network of More than 80,000 Providers, 81 Million Unique Patient Records, and Five Billion Annual Data... Read More →
Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies
/
Date21 Sep 2016
CAMBRIDGE, United Kingdom, Sept. 21, 2016 (GLOBE NEWSWIRE) — Artios Pharma Ltd., a new private company focussed on developing novel cancer treatments targeting the DNA... Read More →
Global Cervical Cancer Diagnostic Test Market worth USD 9.46 Billion by 2021: Zion Market Research
/
Date21 Sep 2016
Sarasota, FL, Sept. 21, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy,... Read More →
CDPHP Health Plans Continue to Rate Among the Highest for Quality in NY, Nation
/
Date20 Sep 2016
ALBANY, N.Y., Sept. 20, 2016 (GLOBE NEWSWIRE) — For more than 30 years, CDPHP has taken great pride in its commitment to quality, and that... Read More →
Sharecare to Host Twitter Chat on Fitness and Physical Activity
/
Date20 Sep 2016
ATLANTA, Sept. 20, 2016 (GLOBE NEWSWIRE) — Sharecare, the digital health company helping people manage all their health in one place, will host a Twitter... Read More →
Adamas Announces Results of EASE LID 3, a Pivotal Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Parkinson’s Disease Patients at the 4th World Parkinson Congress
/
Date20 Sep 2016
EMERYVILLE, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the results of the EASE LID 3 study, the second Phase 3... Read More →
American Airlines to Donate $1M to Answer ALS Foundation
/
Date20 Sep 2016
FORT WORTH, Texas, Sept. 20, 2016 (GLOBE NEWSWIRE) — American Airlines this year will begin a multi-year financial commitment of $1 million to the Answer... Read More →
Arthritis Society invests $4.82 million to further arthritis research in Canada
/
Date20 Sep 2016
TORONTO, Sept. 20, 2016 (GLOBE NEWSWIRE) — The Arthritis Society today announced that its 2016-17 funding commitment for arthritis research will be $4.82 million, spanning... Read More →
Endologix Reports Positive Clinical Data from Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
/
Date20 Sep 2016
IRVINE, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data... Read More →